This article examines how microneedles mitigate protein corona effects to enhance drug delivery in tissues, suggesting novel strategies.
Due to adsorption of proteins, abundant protein molecules quickly bind to the nano-particles' (NPs) surface when they enter the bloodstream, forming a "protein corona." The protein corona leads to rapid clearance of NPs, thereby impeding efficient drug delivery. Notably, mi-croneedles (MNs) can reduce protein corona formation by altering the route of drug entry and confining the drug within the local tissue microenvironment. This article outlines the relationship between drug-loaded MNs and the protein corona and proposes strategies to suppress its for-mation. Furthermore, it underscores that the synergy between microneedles and stealth nanocar-riers can minimize the detrimental effects associated with protein corona formation.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: